Blog

Keeping Cerebrospinal Fluid Leaks and Meningitis at Bay. Defining the optimal exit strategy in pituitary and skull base tumor surgery, PNI authors have published a landmark article in the May 2018 issue of Journal of Neurosurgery. Leading the way in the field of minimally invasive surgery, PNI’s expert team reported on intraoperative repair of skull base defects and prevention of post-operative CSF leaks and meningitis in over 500 patients with pituitary tumors and skull base tumors.

The Wizard201G clinical trial from Boston Biomedical Inc. is a vaccine treatment for patients with recurrent or progressive GBM following initial treatment. Pacific Neuroscience Institute is a site for this phase 2 study which is currently recruiting. Contact us for eligibility criteria at 310-582-7460.

Check out Pacific Neuroscience Institute's advanced clinical trials line up for May 2018. PNI is very excited to announce a new clinical trial for the assessment and treatment of patients with newly diagnosed glioblastoma. Find out how Dr. Santosh Kesari's protocol tackles brain cancer treatment in a whole new way.